To compare the clinical effect and mechanism of transcutaneous acupoint electrical stimulation and acupoint catgut embedding in preventing postoperative nausea and vomiting in thyroid surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023275

Enrollment

Unknown

Registered

2019-05-20

Start date

2019-05-31

Completion date

Unknown

Last updated

2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid mass disease

Interventions

Controll:granisetron

electrical stimulation:transcutaneous acupoint electrical stimulation

embedding:acupoint catgut embedding

Eligibility

Sex/Gender

All

Age

25 Years to 60 Years

Inclusion criteria

Inclusion criteria: Aged 25 to 60 years, ASA class I ~ II, BMI < 30 patients with thyroid surgery.

Exclusion criteria

Exclusion criteria: Patients with electrolyte disturbance, heart conduction disease, major organ physiological function damage, and a history of taking drugs that interfere with heart conduction and lower blood pressure.

Design outcomes

Primary

Measure	Time frame
Frequency and degree of PONV occurrence;	—

Secondary

Measure	Time frame
5-HT;adrenaline;norepinephrine;	—

Countries

China

Contacts

Public ContactWanchao Yang

Department of Anesthesiology, Second Affiliated Hospital of Harbin Medical University

dachao_1980@126.com+86 13796636010

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026